Literature DB >> 11069001

Technetium-99m MDP bone scintigraphic findings of hypercalcemia in accelerated phase of chronic myelogenous leukemia.

H S Kwak1, M H Sohn, S T Lim, J Y Kwak, C Y Yim.   

Abstract

Hypercalcemia in accelerated phase of chronic myelogenous leukemia (CML) is very rare. Its pathogenesis is considered humoral hypercalcemia of malignancies mediated by parathyroid hormone-related protein (PTHrP). In severe hypercalcemia, calcifications in kidneys, skin, vessels, heart, and stomach may occur. Our two cases were admitted because of severe hypercalcemia in accelerated phase of CML. On Tc-99m methylene diphosphonate (MDP) bone scintigraphies, a marked tracer accumulation was seen in the lung, heart, stomach and kidney. We report increased tracer accumulation of multiple organs on Tc-99m MDP bone scintigraphy in two rare hypercalcemic patients with CML.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069001      PMCID: PMC3054685          DOI: 10.3346/jkms.2000.15.5.598

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  4 in total

1.  Use of imatinib mesylate for favorable control of hypercalcemia mediated by parathyroid hormone-related protein in a patient with chronic myelogenous leukemia at blast phase.

Authors:  Natsuki Miyoshi; Hideo Tanaka; Takuo Ito; Yuta Katayama; Hiromasa Niimi; Hideo Hyodo; Akiro Kimura
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

Review 2.  Leukemic arthritis and severe hypercalcemia in a man with chronic myeloid leukemia: a case report and review of the literature.

Authors:  Pongprueth Rujirachun; Apichaya Junyavoraluk; Weerapat Owattanapanich; Voraparee Suvannarerg; Sirinart Sirinvaravong
Journal:  J Med Case Rep       Date:  2018-09-10

3.  Primary hyperparathyroidism in a case of chronic myelogenous leukemia.

Authors:  Nasim Valizadeh; Faramarz Herfehdoust; Neda Valizadeh; Sara Vossoghian
Journal:  Indian J Endocrinol Metab       Date:  2013-09

4.  Calcinosis cutis: a rare complication of chronic myeloid leukemia.

Authors:  Azam Samdani
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.